Surgery Partners, Inc. (SGRY) research
Surgery Partners, Inc.- Sector
- Healthcare
- Industry
- Medical Care Facilities
- Last price
- $13.32
- As of
Surgery Partners, Inc. (SGRY): 2 institutional managers tracked by Kresmion reported non-option positions in their 2026Q2 Form 13F filings, and the most recent SEC filing on record for the company is a Form 8-K filed 2026-09-17.
As of . Source: SEC EDGAR filings for SGRY. Method and limitations.
Share the SGRY intelligence card
See the full SGRY dossier
Price with insider and filing markers, who is positioning, fundamentals and peers for SGRY on one page. Preview it with sample data, then open it live with a free account.
Preview the SGRY dossierActive signals for SGRY
- highINSTITUTIONAL_EXIT
RENAISSANCE TECHNOLOGIES LLC cut 50% of SGRY (2026Q2)
- highINSTITUTIONAL_SURGE
CITADEL ADVISORS LLC added +159% to SGRY (2026Q2)
- highINSTITUTIONAL_SURGE
CITADEL ADVISORS LLC added +64% to SGRY (2026Q2)
- mediumEARNINGS_BEAT
Q2-2026: Beat consensus by 68.1%, EPS $0.10 vs $0.0595 estimate
- highINSTITUTIONAL_SURGE
MILLENNIUM MANAGEMENT LLC added +111% to SGRY (2026Q1)
FREE, NO ACCOUNT
Every signal on SGRY, as it fires
You are seeing 5 of 11 signals recorded on SGRY since 2026-05-26.
The five above landed across 3 days. The other 6 were recorded on 2 other days.
No fixed schedule: it goes out when the data has something in it. Unsubscribe anytime. We never sell your data.
Largest reported share positions in SGRY (2026Q2)
| Manager / security | Market value | % portfolio | QoQ |
|---|---|---|---|
| CITADEL ADVISORS LLCCUSIP 86881A100 · 2026Q2 | $4.9M | 0.00% | , |
| RENAISSANCE TECHNOLOGIES LLCCUSIP 86881A100 · 2026Q2 | $2.2M | 0.00% | , |
Quarterly SEC Form 13F disclosures from the managers Kresmion tracks, not a complete ownership ranking. Non-option holdings only; reported put and call positions are excluded. Different securities are labeled by CUSIP. Values are reporting-period snapshots, not current position values. Filings can arrive up to 45 days after quarter-end.
Recent SEC filings, SGRY
- 8-KSEC EDGAR ↗
- 10-QSEC EDGAR ↗
- 8-KSEC EDGAR ↗
- 8-KSEC EDGAR ↗
- 8-KSEC EDGAR ↗
- 8-KSEC EDGAR ↗
- 10-QSEC EDGAR ↗
- 8-KSEC EDGAR ↗
- 10-KSEC EDGAR ↗
- 8-KSEC EDGAR ↗
SGRY against its peers
SGRY's operating margin of 11.8% ranks in the 79th percentile of 16 Medical Care Facilities sub-industry peers, fiscal periods ending between 2025-12-31 and 2026-06-30.
| Metric | SGRY | Peer median | Percentile | n |
|---|---|---|---|---|
| Revenue FY | 3.3B USD | 1.4B USD | 81 | 17 |
| Gross margin | n/a | 23.0% | n/a | 5 |
| Operating margin | 11.8% | 2.1% | 79 | 16 |
| Net margin | -2.4% | 2.8% | 24 | 18 |
| Return on equity | -4.5% | 8.8% | 16 | 15 |
| P / E | n/a | 24.4x | n/a | 10 |
Peers (18): SNDA, ADUS, ASTH, ARDT, NUTX, GRDN, AGL, INNV, NHC, LFST, CON, TOI, MCTA, SRTA, CYH, FMS, AIRS, JYNT. Left out: LTGHY (no annual filing), BUHPY (no annual filing), GMRS (no annual filing), AUNA (no annual filing), HWAIF (no annual filing), WW (no annual filing), FSNUY (no annual filing). Fiscal periods ending between 2025-12-31 and 2026-06-30. Every figure is one full fiscal year read from one annual filing (SGRY: 10-K), reported in USD. Nothing is trailing twelve months and nothing is converted between currencies. Source: SEC EDGAR XBRL company facts (public domain); prices from Kresmion's daily equity market-data snapshot. Open the full comparison.
Related tickers
See more SGRY signals as they fire
Kresmion publishes filings, 13F flows, on-chain whale activity, and cross-asset signals in real time. Open a live board scoped to SGRYand get the insider, 13F, options, and confluence read in one view.